Denmark
  • Europe
    • FR
    • DE
    • IT
    • ES
    • PL
    • BE
    • NL
    • LU
    • CH
    • NO
    • SE
    • FI
    • EE
    • LV
    • LT
  • Denmark
    • Faroe Islands
    • Greenland
    • Copenhagen
  • Business
    • Mærsk
    • Novo Nordisk
    • DSV
    • Ørsted
    • Danske Bank
    • Vestas Wind Systems
    • LEGO
    • DFDS
  • Nordics
    • Stockholm
    • Oslo
    • Helsinki
  • Baltics
    • Tallinn
    • Riga
    • Vilnius
  • Benelux
    • Brussels
    • Amsterdam
  • Warsaw
  • Berlin
  • NATO
  • UK
  • US
  • Africa
  • Amsterdam
  • Berlin
  • Brussels
  • Copenhagen
  • Danske Bank
  • Denmark
  • DFDS
  • DSV
  • Faroe Islands
  • Greenland
  • Helsinki
  • LEGO
  • Mærsk
  • Novo Nordisk
  • Ørsted
  • Oslo
  • Riga
  • Stockholm
  • Tallinn
  • Vestas Wind Systems
  • Vilnius
  • Warsaw
Denmark
  • Europe
    • FR
    • DE
    • IT
    • ES
    • PL
    • BE
    • NL
    • LU
    • CH
    • NO
    • SE
    • FI
    • EE
    • LV
    • LT
  • Denmark
    • Faroe Islands
    • Greenland
    • Copenhagen
  • Business
    • Mærsk
    • Novo Nordisk
    • DSV
    • Ørsted
    • Danske Bank
    • Vestas Wind Systems
    • LEGO
    • DFDS
  • Nordics
    • Stockholm
    • Oslo
    • Helsinki
  • Baltics
    • Tallinn
    • Riga
    • Vilnius
  • Benelux
    • Brussels
    • Amsterdam
  • Warsaw
  • Berlin
  • NATO
  • UK
  • US
  • Africa

Browsing Tag

NVO

22 posts
NNovo Nordisk
Is its obesity drug dominance strong enough to sustain long-t
Read More

Is its obesity drug dominance strong enough to sustain long-t

  • 2026-04-21
With blockbuster drugs like Ozempic driving massive growth, you need to know if Novo Nordisk’s leadership in diabetes…
NNovo Nordisk
Is obesity drug dominance strong enough to unlock new upside?
Read More

Is its obesity drug dominance strong enough to sustain long-t

  • 2026-04-21
With blockbuster drugs like Wegovy driving massive growth, you need to know if Novo Nordisk’s lead in the…
NNovo Nordisk
Novo Nordisk updates DKK 15B share buyback | NVO SEC Filing
Read More

Novo Nordisk’s etavopivat hits phase 3 goals in SCD | NVO SEC Filing

  • 2026-04-20
  UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   ________________   FORM 6-K ________________   REPORT…
NNovo Nordisk
LLY Chart
Read More

The $1 Trillion Race: Why Eli Lilly Is Leaving Novo Nordisk in the Dust

  • 2026-04-15
Key Points Eli Lilly has a stronger weight-loss portfolio than Novo Nordisk. Eli Lilly also has a deep…
NNovo Nordisk
Novo Nordisk updates DKK 15B share buyback | NVO SEC Filing
Read More

Novo Nordisk updates DKK 15B share buyback | NVO SEC Filing

  • 2026-04-07
  UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   ________________   FORM 6-K ________________   REPORT…
NNovo Nordisk
Novo Nordisk wins FDA approval for Awiqli insulin | NVO SEC Filing
Read More

Novo Nordisk AGM approves 2025 dividend, buyback | NVO SEC Filing

  • 2026-03-28
  UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   ________________   FORM 6-K ________________   REPORT…
NNovo Nordisk
Novo Nordisk wins FDA approval for Awiqli insulin | NVO SEC Filing
Read More

Novo Nordisk wins FDA approval for Awiqli insulin | NVO SEC Filing

  • 2026-03-28
  UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   ________________   FORM 6-K ________________   REPORT…
NNovo Nordisk
Novo Nordisk wins FDA approval for Wegovy HD | NVO SEC Filing
Read More

Novo Nordisk updates 2026 share bu… | NVO SEC Filing

  • 2026-03-25
  UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   ________________   FORM 6-K ________________   REPORT…
NNovo Nordisk
Novo Nordisk wins FDA approval for Wegovy HD | NVO SEC Filing
Read More

Novo Nordisk wins FDA approval for Wegovy HD | NVO SEC Filing

  • 2026-03-21
  UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   ________________   FORM 6-K ________________   REPORT…
NNovo Nordisk
Multiple semaglutide injections in a box.
Read More

Down Near Its 5-Year Low, Is Novo Nordisk Stock Too Cheap to Pass Up?

  • 2026-03-20
Key Points Novo Nordisk unveiled a troubling guidance for 2026, which tanked the stock. It recently reached a…
NNovo Nordisk
Multiple semaglutide injections in a box.
Read More

Down Near Its 5-Year Low, Is Novo Nordisk Stock Too Cheap to Pass Up?

  • 2026-03-20
Key Points Novo Nordisk unveiled a troubling guidance for 2026, which tanked the stock. It recently reached a…
NNovo Nordisk
DIA
Read More

Novo Nordisk Receives FDA Approval For Higher Dose Of Its Weight-Loss Drug Wegovy

  • 2026-03-19
The company stated that Wegovy HD received the FDA’s accelerated approval based on results from the STEP UP…
Denmark
www.europesays.com